GlassScriptPhysician profile
Scott R Larson
NPI 1154562973
$875.92
in general payments reported to CMS, 2019-2025
10 companies · $93.47 in 2025
The $93.47 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $60.99 · 2021: $84.09 · 2022: $159 · 2023: $126 · 2024: $192 · 2025: $93.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $411.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $213.61 | 2019-2023 | Bridion |
| Chiesi USA, INC. | $176.69 | 2019-2025 | Cleviprex |
| Pacira Pharmaceuticals Incorporated | $145.92 | 2019-2025 | Exparel |
| Abiomed | $119.84 | 2024 | Impella |
| Medtronic, INC. | $101.59 | 2022-2023 | Mcgrath Mac |
| Depuy Synthes Sales INC. | $39.02 | 2024 | Exparel, Na |
| Avanos Medical | $22.74 | 2019 | |
| Exeltis, USA INC. | $22.73 | 2020 | |
| Edwards Lifesciences Corporation | $17.34 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $16.44 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Larson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.